Brand Name
Demser
Generic Name
Metyrosine
View Brand Information FDA approval date: October 03, 1979
Classification: Catecholamine Synthesis Inhibitor
Form: Capsule
What is Demser (Metyrosine)?
Metyrosine capsules are indicated in the treatment of patients with pheochromocytoma for: 1. Preoperative preparation of patients for surgery. 2. Management of patients when surgery is contraindicated. 3. Chronic treatment of patients with malignant pheochromocytoma. Metyrosine capsules are not recommended for the control of essential hypertension.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment